Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H25N3O2 |
| Molecular Weight | 339.4314 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(CCCCN1CCOCC1)NC2=CC=C(C=C2)C3=CN=CC=C3
InChI
InChIKey=XCHIZTUBUXZESJ-UHFFFAOYSA-N
InChI=1S/C20H25N3O2/c24-20(5-1-2-11-23-12-14-25-15-13-23)22-19-8-6-17(7-9-19)18-4-3-10-21-16-18/h3-4,6-10,16H,1-2,5,11-15H2,(H,22,24)
| Molecular Formula | C20H25N3O2 |
| Molecular Weight | 339.4314 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/19223665
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19223665
SEN12333 is a alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
CNS Activity
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P36544 Gene ID: 1139|||89832 Gene Symbol: CHRNA7 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/19223665 |
1.6 µM [EC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
PubMed
| Title | Date | PubMed |
|---|---|---|
| SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist. | 2009-07-15 |
|
| Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders. | 2009-05 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/19223665
SEN12333 was administered intraperitoneally at the doses of 1, 3, and 10 mg/kg.
Route of Administration:
Intraperitoneal
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 22:29:48 GMT 2025
by
admin
on
Tue Apr 01 22:29:48 GMT 2025
|
| Record UNII |
M92TU1EZ75
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
45484303
Created by
admin on Tue Apr 01 22:29:48 GMT 2025 , Edited by admin on Tue Apr 01 22:29:48 GMT 2025
|
PRIMARY | |||
|
874450-44-9
Created by
admin on Tue Apr 01 22:29:48 GMT 2025 , Edited by admin on Tue Apr 01 22:29:48 GMT 2025
|
PRIMARY | SCIFINDER | ||
|
DTXSID30670437
Created by
admin on Tue Apr 01 22:29:48 GMT 2025 , Edited by admin on Tue Apr 01 22:29:48 GMT 2025
|
PRIMARY | |||
|
M92TU1EZ75
Created by
admin on Tue Apr 01 22:29:48 GMT 2025 , Edited by admin on Tue Apr 01 22:29:48 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> AGONIST |
WAY-317538 (SEN-12333) IS A DRUG THAT ACTS AS A POTENT AND SELECTIVE FULL AGONIST FOR THE .ALPHA.7 SUBTYPE OF NEURAL NICOTINIC ACETYLCHOLINE RECEPTORS.
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |